| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9410320AGB9410320D0 (en) | 1994-05-24 | 1994-05-24 | Novel therapeutic method |
| AU25347/95AAU2534795A (en) | 1994-05-24 | 1995-05-24 | Combination product of dichloroacetic acid and an nmda antagonist |
| PCT/GB1995/001205WO1995031986A1 (en) | 1994-05-24 | 1995-05-24 | Combination product of dichloroacetic acid and an nmda antagonist |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9410320AGB9410320D0 (en) | 1994-05-24 | 1994-05-24 | Novel therapeutic method |
| Publication Number | Publication Date |
|---|---|
| GB9410320D0true GB9410320D0 (en) | 1994-07-13 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB9410320APendingGB9410320D0 (en) | 1994-05-24 | 1994-05-24 | Novel therapeutic method |
| Country | Link |
|---|---|
| AU (1) | AU2534795A (en) |
| GB (1) | GB9410320D0 (en) |
| WO (1) | WO1995031986A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004000353A1 (en)* | 2002-06-20 | 2003-12-31 | The Governors Of The University Of Alberta | Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| EP1908462A3 (en)* | 2002-06-20 | 2008-06-25 | The Governors Of The University Of Alberta | Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
| US6693133B1 (en) | 2002-10-07 | 2004-02-17 | University Of Alberta | Methods of cardioprotection using dichloroacetate in combination with an inotrope |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| JP2007517853A (en)* | 2004-01-16 | 2007-07-05 | ザ ガバナーズ オブ ザ ユニバーシティ オブ アルバータ | Dichloroacetate in combination with cardiotonic cardiotonic |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| DK2091948T3 (en) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
| AU2008220785B2 (en) | 2007-03-01 | 2013-02-21 | Vivoryon Therapeutics N.V. | New use of glutaminyl cyclase inhibitors |
| EP2865670B1 (en) | 2007-04-18 | 2017-01-11 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
| CA2772488C (en) | 2009-09-11 | 2018-04-17 | Probiodrug Ag | Heterocyclic derivatives as inhibitors of glutaminyl cyclase |
| ES2586231T3 (en) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Glutaminyl cyclase inhibitors |
| JP5688745B2 (en) | 2010-03-10 | 2015-03-25 | プロビオドルグ エージー | Heterocyclic inhibitor of glutaminyl cyclase (QC, EC 2.3.2.5) |
| US8541596B2 (en) | 2010-04-21 | 2013-09-24 | Probiodrug Ag | Inhibitors |
| JP6050264B2 (en) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
| DK3461819T3 (en) | 2017-09-29 | 2020-08-10 | Probiodrug Ag | GLUTAMINYL CYCLASE INHIBITORS |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4631294A (en)* | 1985-07-05 | 1986-12-23 | University E.M., Inc. | Treatment of cerebral ischemia with dichloroacetate |
| ATE135206T1 (en)* | 1988-08-12 | 1996-03-15 | Astra Ab | ARYLALKYLAMINES AND AMIDES WITH SPACE-RESOLVING AND NEUROPROTECTIVE EFFECTS |
| Publication number | Publication date |
|---|---|
| AU2534795A (en) | 1995-12-18 |
| WO1995031986A1 (en) | 1995-11-30 |
| Publication | Publication Date | Title |
|---|---|---|
| AP9500717A0 (en) | Novel method | |
| ZA9533B (en) | Pentolifylline therapy | |
| GB9410320D0 (en) | Novel therapeutic method | |
| GB2289946B (en) | Method | |
| GB9515868D0 (en) | Therapeutic method | |
| GB9414624D0 (en) | Novel method | |
| GB9415073D0 (en) | Novel method | |
| GB9507229D0 (en) | Novel method | |
| GB9411549D0 (en) | Novel therapeutic method | |
| GB9410319D0 (en) | Novel therapeutic method | |
| GB9410693D0 (en) | Novel therapeutic method | |
| GB9410326D0 (en) | Novel therapeutic method | |
| GB9414242D0 (en) | Therapeutic method | |
| GB9401566D0 (en) | Method | |
| GB9510671D0 (en) | Novel therapeutic method | |
| GB9511927D0 (en) | Novel therapeutic method | |
| GB9511354D0 (en) | Novel therapeutic method | |
| GB9510663D0 (en) | Novel therapeutic method | |
| GB9517851D0 (en) | New therapeutic method | |
| GB9520585D0 (en) | Therapeutic method | |
| GB9310568D0 (en) | Novel therapeutic method | |
| GB9310831D0 (en) | Novel therapeutic method | |
| GB9311786D0 (en) | Novel therapeutic method | |
| GB9316303D0 (en) | Novel therapeutic method | |
| GB9311787D0 (en) | Novel therapeutic method |